‘Solve all diseases,’ you say?
Demis Hassabis just promised to 'solve all disease' at Google I/O. Here's what that actually means for drug discovery.
Why it matters
Google DeepMind is positioning AI as a transformative force in pharmaceutical R&D and disease treatment, raising critical questions about AI's role in healthcare, realistic timelines for drug discovery, and the gap between research claims and clinical deployment.
The key facts
9 to knowDemis Hassabis announced goal to 'solve all disease' via drug discovery reimagined with AI
Statement made at Google I/O keynote
Involves AlphaFold and AlphaGenome capabilities for scientific applications
Focus on healthcare and pharmaceutical innovation
Demis Hassabis (Google DeepMind CEO) announced goal to 'solve all disease' via drug discovery reimagining
Statement made at Google I/O keynote (May 20, 2026)
Builds on existing AlphaFold and AlphaGenome work
Framed as 'Gemini for Science' initiative
Article frames statement as requiring unpacking—suggests hyperbole or contested interpretation
Go to the source
The Verge AItheverge.com
Publisher excerpt: Let’s unpack what Demis Hassabis said at the end of yesterday’s Google I/O keynote. This is Optimizer, a weekly newsletter sent from Verge senior reviewer Victoria Song that dissects and discusses the latest gizmos and potions that swear they're going to change your life. This week's issue is a…